ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis (OASIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01273779
Recruitment Status : Suspended (Data Safety Monitoring Board recommendation)
First Posted : January 11, 2011
Last Update Posted : February 3, 2012
Sponsor:
Information provided by (Responsible Party):
Agennix

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Estimated Primary Completion Date : January 2014
  Estimated Study Completion Date : December 2014